Cardiology

Episodes 1-16 of 74

• 

  RestartResume

  The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC

  RestartResume

  The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC

  MinuteCE®

  The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC

  0.75 program credits

  • 

    

    Harry Yoon, MD

  • 

    

    Jaffer Ajani, MD

  0.75 program credits

• 

  RestartResume

  ICI Combination Regimens for First-Line Treatment of Metastatic ESCC

  RestartResume

  ICI Combination Regimens for First-Line Treatment of Metastatic ESCC

  MinuteCE®

  ICI Combination Regimens for First-Line Treatment of Metastatic ESCC

  0.75 program credits

  • 

    

    Harry Yoon, MD

  • 

    

    Jaffer Ajani, MD

  0.75 program credits

• 

  RestartResume

  Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC

  RestartResume

  Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC

  MinuteCE®

  Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC

  0.75 program credits

  • 

    

    Harry Yoon, MD

  • 

    

    Jaffer Ajani, MD

  0.75 program credits

• 

  RestartResume

  Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC

  RestartResume

  Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC

  MinuteCE®

  Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC

  0.75 program credits

  • 

    

    Harry Yoon, MD

  • 

    

    Jaffer Ajani, MD

  0.75 program credits

• 

  RestartResume

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations

  RestartResume

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations

  MinuteCE®

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations

  1.00 program credit

  • 

    

    Valeria Caso, MD, PhD

  1.00 program credit

• 

  RestartResume

  Patient Case Study: Cancer-Associated Thrombosis

  RestartResume

  Patient Case Study: Cancer-Associated Thrombosis

  MinuteCE®

  Patient Case Study: Cancer-Associated Thrombosis

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 program credit

• 

  RestartResume

  Setting the Stage of Real-World Data vs RCT

  RestartResume

  Setting the Stage of Real-World Data vs RCT

  MinuteCE®

  Setting the Stage of Real-World Data vs RCT

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  1.00 program credit

• 

  RestartResume

  Trade off: Ischemic/Thrombotic vs Bleeding  

  RestartResume

  Trade off: Ischemic/Thrombotic vs Bleeding  

  MinuteCE®

  Trade off: Ischemic/Thrombotic vs Bleeding  

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  1.00 program credit

• 

  RestartResume

  Patient Case Study: Obesity

  RestartResume

  Patient Case Study: Obesity

  MinuteCE®

  Patient Case Study: Obesity

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  1.00 program credit

• 

  RestartResume

  Patient Case Study: Elderly

  RestartResume

  Patient Case Study: Elderly

  MinuteCE®

  Patient Case Study: Elderly

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  1.00 program credit

• 

  RestartResume

  How Do We Translate Real-World AF Data Into Everyday Clinical Practice?

  RestartResume

  How Do We Translate Real-World AF Data Into Everyday Clinical Practice?

  MinuteCE®

  How Do We Translate Real-World AF Data Into Everyday Clinical Practice?

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  1.00 program credit

• 

  RestartResume

  How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?

  RestartResume

  How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?

  MinuteCE®

  How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?

  1.00 program credit

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 program credit

• 

  MinuteCE®

  AF and VTE: Global Considerations in the Evolving Space of Real-World Data

  1.00 credit 10 episodes

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 credit 10 episodes

• 

  RestartResume

  Patient Case Study: Obesity and VTE

  RestartResume

  Patient Case Study: Obesity and VTE

  MinuteCE®

  Patient Case Study: Obesity and VTE

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 program credit

• 

  RestartResume

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations  

  RestartResume

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations  

  MinuteCE®

  Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations  

  1.00 program credit

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 program credit

• 

  RestartResume

  Right Heart Catheterization: Mastery of Precision Techniques

  RestartResume

  Right Heart Catheterization: Mastery of Precision Techniques

  CME/CE Broadcast Replay

  Right Heart Catheterization: Mastery of Precision Techniques

  1.00 credit

  • 

    

    Richard Krasuski, MD

  • 

    

    Vallerie V. McLaughlin, MD

  1.00 credit